Detected ·
VectorY
€74.5M—
VectorY, a Forbion portfolio company, has raised €74.5 million to advance its clinical and preclinical pipeline for neurodegenerative diseases, including ALS and Huntington's disease.
- Website
- www.vectorytx.com
- linkedin.com/company/vectorytx1
- Amount
- €74 500 000 EUR
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-11 16:03:07 UTC
- Signal ID
- 123c78a5-4d7d-4767-a1e0-2550aec8026e
As the API returns it
{
"id": "123c78a5-4d7d-4767-a1e0-2550aec8026e",
"created_at": "2026-11-11T16:03:07.618870Z",
"company_name": "VectorY",
"company_website_url": "www.vectorytx.com",
"company_linkedin_url": "https://www.linkedin.com/company/vectorytx1",
"event_type": "funding",
"funding_amount": 74500000,
"funding_currency": "EUR",
"funding_stage": null,
"message": "*VectorY, a Forbion portfolio company, has raised €74.5 million to advance its clinical and preclinical pipeline for neurodegenerative diseases, including ALS and Huntington's disease.*"
}